PROFOUND, YET REVERSIBLE, HEART-FAILURE SECONDARY TO 5-FLUOROURACIL

被引:22
作者
CHAUDARY, S
SONG, SYT
JASKI, BE
机构
关键词
D O I
10.1016/0002-9343(88)90615-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:454 / 456
页数:3
相关论文
共 20 条
[1]  
BRISTON MR, 1981, AM HEART J, V10, P709
[2]  
DENT RG, 1975, LANCET, V1, P347
[3]  
FREEMAN NJ, 1988, CANCER-AM CANCER SOC, V61, P36, DOI 10.1002/1097-0142(19880101)61:1<36::AID-CNCR2820610108>3.0.CO
[4]  
2-6
[5]  
GAMMUCI T, 1980, TUMORI, V66, P635
[6]  
HASKEL CM, 1984, CANC TREATMENT, P43
[7]   CLINICAL AND MORPHOLOGIC CARDIAC FINDINGS AFTER ANTHRACYCLINE CHEMOTHERAPY - ANALYSIS OF 64 PATIENTS STUDIED AT NECROPSY [J].
ISNER, JM ;
FERRANS, VJ ;
COHEN, SR ;
WITKIND, BG ;
VIRMANI, R ;
GOTTDIENER, JS ;
BECK, JR ;
ROBERTS, WC .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (07) :1167-1174
[8]  
Kleiman N S, 1987, Am J Med, V82, P566, DOI 10.1016/0002-9343(87)90465-7
[9]   CARDIAC TOXICITY OF 5-FLUOROURACIL - A STUDY ON 1083 PATIENTS [J].
LABIANCA, R ;
BERETTA, G ;
CLERICI, M ;
FRASCHINI, P ;
LUPORINI, G .
TUMORI, 1982, 68 (06) :505-510
[10]   CARDIOTOXICITY AS A RESULT OF 5-FLUOROURACIL THERAPY [J].
LEONE, B ;
RABINOVICH, M ;
FERRARI, CR ;
BOYER, J ;
ROSSO, H ;
STRAUSS, E .
TUMORI, 1985, 71 (01) :55-57